1. A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior.
- Author
-
De Rossi P, Harde E, Dupuis JP, Martin L, Chounlamountri N, Bardin M, Watrin C, Benetollo C, Pernet-Gallay K, Luhmann HJ, Honnorat J, Malleret G, Groc L, Acker-Palmer A, Salin PA, and Meissirel C
- Subjects
- Animals, Behavior, Animal, Cell Culture Techniques, Excitatory Postsynaptic Potentials, Fear, Hippocampus metabolism, Mice, Neuronal Plasticity physiology, Neurons metabolism, Protein Subunits, Receptors, Glutamate metabolism, Receptors, N-Methyl-D-Aspartate metabolism, Synapses metabolism, Synaptic Transmission physiology, Vascular Endothelial Growth Factor A physiology, Vascular Endothelial Growth Factor Receptor-2 physiology, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor Receptor-2 metabolism
- Abstract
Vascular endothelial growth factor (VEGF) is known to be required for the action of antidepressant therapies but its impact on brain synaptic function is poorly characterized. Using a combination of electrophysiological, single-molecule imaging and conditional transgenic approaches, we identified the molecular basis of the VEGF effect on synaptic transmission and plasticity. VEGF increases the postsynaptic responses mediated by the N-methyl-D-aspartate type of glutamate receptors (GluNRs) in hippocampal neurons. This is concurrent with the formation of new synapses and with the synaptic recruitment of GluNR expressing the GluN2B subunit (GluNR-2B). VEGF induces a rapid redistribution of GluNR-2B at synaptic sites by increasing the surface dynamics of these receptors within the membrane. Consistently, silencing the expression of the VEGF receptor 2 (VEGFR2) in neural cells impairs hippocampal-dependent synaptic plasticity and consolidation of emotional memory. These findings demonstrated the direct implication of VEGF signaling in neurons via VEGFR2 in proper synaptic function. They highlight the potential of VEGF as a key regulator of GluNR synaptic function and suggest a role for VEGF in new therapeutic approaches targeting GluNR in depression.
- Published
- 2016
- Full Text
- View/download PDF